Literature DB >> 15331192

Pulmonary Langerhans' cell histiocytosis.

Robert Vassallo1, Jay H Ryu.   

Abstract

Pulmonary Langerhans' cell histiocytosis (PLCH) is an uncommon but important cause of interstitial lung disease, and it occurs predominantly in adult cigarette smokers. PLCH belongs to the spectrum of Langerhans' cell histiocytosis (LCH), diseases characterized by uncontrolled proliferation and infiltration of various organs by Langerhans' cells. Other clinical entities within this spectrum of LCH are seen in adults and children and vary in severity from mild disease that requires no therapy to severe disseminated forms with extensive organ involvement and high mortality. Organ systems involved by LCH may include skin, bone, pituitary gland, lymph nodes, and lungs. Although LCH is approximately three times more common in children than adults, pulmonary involvement is much more common in adults with LCH, in whom it frequently occurs as the sole organ involved with disease. This article summarizes recent advances and current understanding of PLCH.

Entities:  

Mesh:

Year:  2004        PMID: 15331192     DOI: 10.1016/j.ccm.2004.04.005

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  13 in total

1.  An unusual radiological presentation of pulmonary Langerhans' cell histiocytosis.

Authors:  Lucy Burr; Steven Fanning; David Wong; Simon Bowler
Journal:  BMJ Case Rep       Date:  2012-07-03

2.  Bronchoscopic diagnosis of Langerhans cell histiocytosis and lymphangioleiomyomatosis.

Authors:  Sergio Harari; Olga Torre; Roberto Cassandro; Angelo M Taveira-DaSilva; Joel Moss
Journal:  Respir Med       Date:  2012-07-07       Impact factor: 3.415

Review 3.  Unusual causes of pneumothorax.

Authors:  Daniel R Ouellette; Scott Parrish; Robert F Browning; J Francis Turner; Konstantinos Zarogoulidis; Ioanna Kougioumtzi; Georgios Dryllis; Ioannis Kioumis; Georgia Pitsiou; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Theodora Tsiouda; Athanasios Madesis; Theodoros Karaiskos; Paul Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

4.  How I treat Langerhans cell histiocytosis.

Authors:  Carl E Allen; Stephan Ladisch; Kenneth L McClain
Journal:  Blood       Date:  2015-03-31       Impact factor: 22.113

5.  Molecular analysis of BRAF V600E mutation in multiple nodules of pulmonary Langerhans cell histiocytosis.

Authors:  Arno Dimmler; Helene Geddert; Martin Werner; Gerhard Faller
Journal:  Virchows Arch       Date:  2017-02-20       Impact factor: 4.064

6.  An Elderly Smoker Presenting With Pulmonary Langerhans Cell Histiocytosis: An Unusual Demographic.

Authors:  Bilal Malik; Muhammad Ahmad; Atefeh Kalantary; Abhijeet Ghatol
Journal:  Cureus       Date:  2021-05-08

Review 7.  Cigarette smoking and diffuse lung disease.

Authors:  Rajesh R Patel; Jay H Ryu; Robert Vassallo
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Diffuse interstitial lung infiltrates in a smoker with human immunodeficiency virus infection.

Authors:  Viswanath P Vasudevan; Praveen K Jinnur; Vishal Verma; Sasikanth Nallagatla
Journal:  Lung India       Date:  2011-07

9.  Diffuse cystic lung disease in a child.

Authors:  Satnam Kaur; Devendra Mishra; Monica Juneja
Journal:  Lung India       Date:  2015 Mar-Apr

10.  Dramatic and sustained responsiveness of pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension to vasodilator therapy.

Authors:  Adam May; Garvan Kane; Eunhee Yi; Robert Frantz; Robert Vassallo
Journal:  Respir Med Case Rep       Date:  2014-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.